Delivery Order SPE2DB25D3108-SPE2DB25FPDEF
Award Date 6/25/25
Potential Completion Date 6/26/25
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $18,465.65 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568532976 CIMZIA 2X200 MG/ML syringe kits, with a completion date of June 13, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- This is a $8,858.37 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567857284 - CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has an ultimate completion date of April 10, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a $7,149.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a performance period extending through June 12, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a $13,979.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, a medication used to treat various medical conditions. The contract has an ultimate completion date of June 17, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $14,122.12 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567688174 CIMZIA 2X200 MG/ML SYRINGE KITS, a specialty medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen...
- This is a $29,162.91 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, a specialty pharmaceutical product, with a performance period through May 15, 2025. This award is not associated with a set-aside program and represents an open competition. AmerisourceBergen Drug Corp has a significant Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,889.46 firm fixed-price contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, with a completion date of January 22, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a $8,472.36 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of CIMZIA 2X200 MG/ML syringe kits, a specialty medication used for various therapeutic applications. The contract has an ultimate completion date of December 17, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CIMZIA 2X200 MG/ML syringe kits. The $5,257.66 contract has an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation is mentioned, indicating open competition. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,114.45, is for the delivery of 4,568,202 units of the pharmaceutical product CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has a performance period through May 12, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDEFDelivery Order
This is a $8,192.25 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568639728 CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of June 26, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract. The contract supports the federal government's medical procurement needs, particularly for military and veteran healthcare systems.
Generated 9/24/25, 10:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 6/25/25 |